With the objective of discovering novel tumor-associated antigens of the cancer/testis type, we compared the transcriptional profiles of renal cell carcinoma (RCC) and nontumorous kidney and further screened for genes expressed in RCC and testis, but not other normal tissues. In a first step, a representational difference analysis library consisting of approximately 1,900 RCC cDNA clones was generated. Clones were then spotted onto filters and hybridized with cDNA probes derived from a testis-specific cDNA library, a pool of RCCs and a pool of 10 healthy normal tissues, respectively. Based on strong hybridization signals with both RCC and testis, but not normal tissue probes, 185 clones were sequenced and annotated.
Key words: representational difference analysis; transcriptional profiling; renal cell carcinoma; tumor-associated antigen; immunohistochemistryThe discovery of the MAGE family of proteins, based on their recognition by cytotoxic T-lymphocytes (CTL), finally settled a long-standing dispute on the existence of cancer-specific human T cell antigens. 1-7 MAGE genes are expressed in a variety of tumor types, but among normal tissues only in male germ line cells, which, however, lack MHC class I expression and hence the antigenic structures. 8 Subsequently, a number of other genes with similar expression characteristics, usually designated as cancer/ testis (C/T) antigens, were identified. These discoveries were not exclusively based on reactivity with CTLs, but also, as in the case of NY-ESO-1, on reactivity with autologous antibodies, 9,10 or on the comparison of transcript profiles of tumors and normal tissues by representational difference analysis (RDA). 11,12 Examples of antigens identified by the latter approach include the C/T antigens MAGE-1C 13 and LAGE-1. 14 Due to their broad expression in different tumor types, their tumor specificity and their ability to induce both CTL and antibody responses, C/T antigens are considered promising targets for cancer vaccines. Renal cell carcinomas (RCC), however, do not express any of the known C/T antigens at reasonable frequency. RCC seems to be an immunogenic tumor. A number of CTL clones with the capability of lysing both autologous and allogenic RCC cell lines could be raised but the corresponding antigens have not been identified yet. 15 One exception is antigen RU2AS, which is frequently expressed in RCC, but also in normal kidney, testes, bladder and liver. 16 We have set out to systematically search for new C/T antigens of RCC on the basis of their tumor-specific transcriptional profile. To this end we performed RDA between RCC and non-tumorous kidney tissue and selected for candidate antigens on the basis of hybridization with a testis-specific cDNA library. This approach led to the identification of 9D7, a novel human gene overexpressed in RCC.
MATERIAL AND METHODS
Tissue samples and RNA preparationTumors of the kidney and non-tumorous kidney tissue were obtained from patients who underwent radical nephrectomy. Tumor typing was done according to ...